Form 4: Annovis Bio Director Michael Hoffman Granted Stock Options

Director Michael Hoffman receives stock options in Annovis Bio, contingent on shareholder approval of an equity incentive plan amendment.

Summary

• Michael B Hoffman, a director and 10% owner of Annovis Bio, Inc., was granted stock options on November 17, 2023.
• The options allow him to purchase 29,600 shares of common stock at an exercise price of $6.07.
• The options vest immediately upon the grant date and expire on November 17, 2033.
• The grant was contingent upon shareholder approval of an amendment to the 2019 Equity Incentive Plan, which increased the number of shares issuable under the plan from 2,000,000 to 3,000,000; this amendment was approved on June 12, 2024.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The stock option grant is a standard practice, and the shareholder approval of the equity incentive plan amendment suggests confidence in the company's prospects. However, the document itself is simply a regulatory filing and doesn't contain any explicit positive or negative statements.

Positives

• The immediate vesting of the options could incentivize the director to work towards the company's success.
• The shareholder approval of the equity incentive plan amendment indicates confidence in the company's future.

Future Outlook

The document does not contain specific forward-looking statements beyond the details of the stock option grant and the equity incentive plan.

Industry Context

Stock option grants are a common practice in the biotechnology industry to incentivize executives and align their interests with those of shareholders. The size and terms of the grant are typical for a company of Annovis Bio's size and stage of development.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotech industry.
• Companies like Biogen and Amgen also use stock options to incentivize their leadership teams.
• The vesting schedule and exercise price are generally aligned with industry norms, although immediate vesting is less common than graded vesting over several years.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of shareholders, potentially encouraging decisions that increase shareholder value.
• The equity incentive plan amendment allows the company to attract and retain talent through equity-based compensation.

Key Dates